Category: RJ Hamster

RJ Hamster

[Winning Trades] FDR Locks in 106% Gains

[Winning Trade] “FDR” Locks in +57% Gains

With Breakout Alert MIMI!

FDR Member,

This is Michael Reece with “Financial Driven Research” saying congrats on MIMI!

I alerted MIMI on February 9, premarket at approx. $.39, and it rocketed to a premarket high of $.62 today February 13, representing 57% in gains from my initial alert.

Take a look at the Snapshot of Level II below.

[Winning Trade] “FDR” Locks in +49% Gains

With Breakout Alert CHOW!

I alerted CHOW on January 2, premarket at approx. $.92, and it rocketed to a high of $1.38 on Thursday February 12, running up +49% in gains from my initial alert.

Take a look at the Snapshot of Level II below.

If these types of gains I’ve just listed above interest you, which soared up 106% in combined gains, I urge you to pay very close attention to my next breakout play.

Michael Reece

Editor, Financial Driven Research

@ 2026 FinancialDrivenResearch.com. All Rights Reserved. You are receiving this e-mail as part of your subscription to FinancialDrivenResearch. Nothing in this email should be considered personalized fina-ncial advice. FinancialDrivenResearch.com is neither a registered inve-stment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes only and should not be construed as an offer to s-ell or the solicitation of an offer to b-uy any se-curity. FinancialDrivenResearch is a fina-ncial publisher that does not offer any personal fina-ncial advice or advocate the pur-chase or s-ale of any se-curity or inve-stment for any specific individual. This communication is not sponsored. We maintain zero positions in all profiled sto-cks. and do not tra-de in any stoc-ks we feature. We do not, under any circumstances, accept sto-cks as compe-nsation for sponsored a-dve-rtising.

You may unsubscribe or change your contact details at any time.

RJ Hamster

StylesForLess

StylesForLess
— Read on stylesforless.com/

RJ Hamster

🚨 RFK Jr initiative finds POISON in US food…

Cancer-causing TOXINS in your food?

RFK Jr has warned against this for years.

Liberals simply laugh and call him a conspiracy theorist.

But guess what…

Florida just announced that 60% of the candy they tested had sky high levels of arsenic…

A toxic poison known to cause cancer.

Just like his warnings about thecovid vaccine, microplastics and FDA corruption…

Once again Kennedy was RIGHT.

Now, RFK Jr has a new warning for seniors in 2026 that you NEED to hear.

And if you were born before January 1, 1966, THIS affects you most of all.

Get the full facts here.

P.S. Liberals will call this crazy too, until they see the data. Learn why RFK Jr is warning Americans about this emerging health crisis before it’s too late. Watch this video now.

This ad is sent on behalf of NewMarket Health Publishing, LLC. P.O. Box 913, Frederick, MD 21705, USA. If you would like to unsubscribe from receiving offers from NewMarket Health Publishing, LLC, please click here.

At Rest N Invest, our goal is to bring you exclusive opportunities. We believe the message from our business partner above is well worth your attention.

Rest N Invest is provided under the management of Sparks Affiliates, LLC.

Have any questions? Write to us: support@restninvest.com.

Stop getting our promotional messages — unsubscribe here.

848 Main St Ste 10, Billings, MT 59105.

Privacy Policy | Terms & Conditions | Unsubscribe

© 2026 All rights reserved. RestNInvest.com.

RJ Hamster

BREAKING: Laser Weapons Engaged — China Responds

This isn’t science fiction. It’s battlefield reality.

Shocking footage just leaked — revealing a new kind of war, one that combines AI, lasers, and U.S. military power… and it’s already underway in the Pacific. China is watching. And now — they’re reacting.

Top insiders are calling this the “trigger point” of a global shift. The Pentagon is scrambling.

Financial markets are trembling.

But while most are panicking — a few are getting ahead.

One tiny tech company is at the center of this war-tech revolution… and it’s giving ordinary Americans the chance to profit from the fallout.

Watch the footage and discover how to turn chaos into opportunity

All the best,
Simmy Adelman, Publisher
Behind the Markets divider Note from editor:
Fast Financial Boost is dedicated to providing readers like you with unique opportunities. The message above from one of our business associates is one we believe you should take a serious look at. Stark Media LLC holds both the operational and ownership rights to the Fast Financial Boost.

For any personalized assistance or questions, simply reply to this email for a swift resolution. Contact us at support@fastfinancialboost.com for other concerns.

If you no longer wish to receive marketing communication from us, please click here to unsubscribe.

Copyright © 2026 Fast Financial Boost. All Rights Reserved.
222 Delaware St, Ste 2071 New Castle, DE 19720PRIVACY POLICY TERMS & CONDITIONS UNSUBSCRIBE

RJ Hamster

Trump Just Dropped a Bombshell

Trump’s Midnight UltimatumAmerica is at a crossroads.

One executive order from Trump could reshape the nation overnight.

25% tax is just the beginning…

What comes next could shake the entire economy.

Here’s how you can protect yourself >>>

All the best,

Simmy Adelman, Publisher

Behind the MarketsEditor’s
Note:At Your Capital Flare, we strive to deliver insights that matter. Above is a message from one of our trusted associates that we believe will be of great interest to you.You’re receiving this email from Your Capital Flare, a proud member of the Stark Media LLC family.

Our Address: 222 Delaware St, Ste 2071, New Castle, DE 19720

Click here to unsubscribe from these communications — it’s simple and quick.

We value your feedback and appreciate your time. For any assistance or inquiries, feel free to contact us atsupport@yourcapitalflare.com. We’re here to ensure a seamless experience for you.

Thank you for respecting our work.
Privacy Policy Terms & Conditions Unsubscribe Copyright © 2026 Yor Capital Flare. All rights reserved

RJ Hamster

A Major Warning for This ‘Stealth’ Tech Titan

Editor’s note: The markets and our Chaikin Analytics offices will be closed Monday, February 16, for Presidents Day. As a result, we won’t publish our Chaikin PowerFeed e-letter that day. Look for your next issue on Tuesday, February 17.

A Major Warning for This ‘Stealth’ Tech Titan

By Ethan Goldman, junior analyst, Chaikin AnalyticsAmazon’s (AMZN) business keeps evolving…

Of course, Amazon is still the king of online retail. The company’s global retail segments still account for the bulk of revenue.

In fact, Amazon made more than $426 billion of its 2025 sales from its North America segment alone. The company’s international segment brought in nearly $162 billion in sales last year, too.

That’s an eye-popping amount of money. But out of those figures, Amazon only managed to pocket a bit more than $34 billion as income.

Most folks probably only know Amazon for its online retail business. But the company’s main income source is its Amazon Web Services (“AWS”) cloud platform…

Now, I won’t dive into what AWS does again. But just know it’s the largest cloud-service provider in the world by market share.

This segment saw massive revenue growth in 2025. Sales in the AWS segment surged 20% year over year to nearly $129 billion.

Sure, that number is much less than the company’s North American and international sales together.

But Amazon brought in nearly $46 billion from this segment in income.

Folks, that’s roughly $11 billion more operating income than Amazon’s two retail segments combined.

So it’s easy to see why Amazon is investing so much in its high-margin AWS business. I’m talking about investments like Trainium computer chips and numerous AI models.

And yet, news of all this AI spending has hurt the company’s stock. And the Power Gauge is flashing some major warning signs right now…Recommended Links:

PLEASE: Heed Marc Chaikin’s Big New Warning for February 17

He called the 2025 crash 13 days before it unfolded… the 2020 and 2022 crashes… and the 2023 bank run four months before it occurred. Now, he’s warning the public to RAISE CASH for February 17 and get ready for the market’s biggest move in three years. Position yourself by Tuesday, February 17. Click here to learn more.

Land Sale Creates 1,000% Opportunity?

What you’re about to see may make you furious. Or… it could be the biggest 10X opportunity anywhere in the market today. In short, a branch of the U.S. government – housed in a monolithic building in Washington, D.C. – is selling off millions of acres of land that, right now, legally belongs to you as an American. And it’s all for one purpose, to develop a new kind of energy that White House insiders call an “awesome resource.” Billionaires are lining up for a cut. You should too – click here to get the full story.

Amazon Brings in More Income From Cloud Services Than Retail

Keep in mind that Amazon made a total of $80 billion in operating income in 2025. And more than half of that is thanks to AWS.

That $80 billion figure also marked nearly 17% growth in total income from the previous year.

Meanwhile, Amazon also said that it plans to spend $200 billion in capital expenditure (“capex”) in 2026. So the company is betting big that more investment in AI will boost its AWS business.

Of course, Amazon isn’t the only tech company putting a ton of money toward AI…

Last week, I shared that Google parent company Alphabet (GOOGL) plans to spend $185 billion on a similar goal.

Unfortunately for Amazon, the market didn’t appreciate this news…

The company’s stock fell more than 5% the day after the earnings release containing all those massive numbers. And it’s now down about 19% over the past month.

The Power Gauge sees this weakness…

As regular readers will recall, I first shared our system’s warning signs about Amazon on January 29.

At the time, the Power Gauge rated Amazon as “neutral.” And as I mentioned, it had flashed some warnings related to weak relative strength not long before that.

And now, the stock’s recent fall has only made matters worse…

A ‘Double Bearish’ Warning From the Power Gauge

The Power Gauge now gives Amazon a “bearish” rating. It also flagged another sell alert related to weak relative strength on February 6.

That’s the day after Amazon released its fourth-quarter and full-year earnings report for 2025.

Take a look at the chart below…I’ll also note that this is the first time the Power Gauge has rated Amazon as downright “bearish” since March 2023.

On top of all this, our earnings quality (“EQ”) filter in our system is also flashing a warning…

I mentioned this feature earlier this week when I discussed shipping giant United Parcel Service (UPS). And right now, the Power Gauge flags Amazon’s EQ as “low.”

Put simply, our system says that Amazon is having a tough time converting its earnings into cash…Of course, we saw this in Amazon’s recent annual report as well.

I won’t sugarcoat it – Amazon’s current picture in the Power Gauge isn’t good. For now, our system sees more downside ahead for the stock.

Good investing,

Ethan Goldman

Editor’s note: We’ve seen plenty of volatility in the markets so far this year. That also goes for many big-name, popular stocks.

The Power Gauge – with features like the EQ filter – is particularly important for navigating this kind of environment. And it’s why our founder Marc Chaikin is going on camera next Tuesday for a special event…

As he’ll explain, it all relates to a chance to double your money on multiple occasions – if you understand what’s coming next to AI and other breakthrough sectors.

You won’t want to miss this big event. And it’s completely free to attend. Just save your spot for it here.

Market View

Major Indexes and Notable Sectors # HLD: BULLISH NEUTRAL BEARISHDow 30

-1.33%621 3S&P 500

-1.54%109299 89Nasdaq

-2.03%2251 27Small Caps

-2.04%606949 331Bonds

+1.33%Utilities

+1.48%127 3

— According to the Chaikin Power Bar, Small Cap stocks and Large Cap stocks are somewhat Bullish. Major indexes are mixed.* * * *

Sector Tracker

Sector movement over the last 5 daysUtilities+4.99%Materials+4.61%Real Estate+3.98%Energy+3.39%Information Technology+2.64%Consumer Staples+2.63%Industrials+2.6%Health Care+0.75%Consumer Discretionary-1.17%Communication-1.35%Financial-3.0%* * * *

Industry Focus

Telecom Services10253

Over the past 6 months, the Telecom subsector (XTL) has outperformed the S&P 500 by +27.93%. Its Power Bar ratio, which measures future potential, is Very Strong, with more Bullish than Bearish stocks. It is currently ranked #10 of 21subsectors and has moved up 3 slots over the past week.Top Stocks rating HLITHarmonic Inc. rating NTCTNetScout Systems, In rating VSATViasat, Inc.* * * *

Top Movers

Gainers rating EQIX+10.41% rating AKAM+10.35% rating ZBRA+8.57% rating MSI+7.67% rating EXC+6.97%Losers rating APP-19.68% rating BAX-15.99% rating TYL-15.39% rating CHRW-14.54% rating EXPD-13.18%* * * *

Earnings Report

Earnings Surprises rating COIN
Coinbase Global, Inc. Q4 $-2.49 Missed by $-3.45 rating H
Hyatt Hotels Corporation Q4 $1.33 Beat by $0.99 rating ALNY
Alnylam Pharmaceuticals, Inc. Q4 $1.25 Missed by $-0.25 rating ABNB
Airbnb, Inc. Q4 $0.56 Missed by $-0.09 rating TOST
Toast, Inc. Q4 $0.27 Beat by $0.03* * * *

You have received this e-mail as part of your subscription to PowerFeed. If you no longer want to receive e-mails from PowerFeed, click here.

You’re receiving this e-mail at pahovis@aol.com.

For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. – 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized financial advice.

© 2026 Chaikin Analytics, LLC. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Chaikin Analytics, LLC. 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. www.chaikinanalytics.com.

Any brokers mentioned constitute a partial list of available brokers and is for your information only. Chaikin Analytics, LLC, does not recommend or endorse any brokers, dealers, or investment advisors.

Chaikin Analytics forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Chaikin Analytics, LLC (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation.

This work is based on SEC filings, current events, interviews, corporate press releases, and what we’ve learned as financial journalists. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility.

RJ Hamster

What It Means to Be a Former Liberal

February 13, 2026 | Read Online

What It Means to Be a Former Liberal

What happened to liberals?…
The courage to face reality…
Have you heard of the “Presidential Bypass”? It’s a legal loophole the rich use to keep their money. And though you might not know it, you can use the same exact loophole to slash your taxes.

Dear reader,

Four years ago, in the wake of the plague and its vast excesses, I authored an article — “What Happened to Liberals?”

From which:

Liberal: A supporter of a political and social philosophy that promotes individual rights, civil liberties, democracy and free enterprise.

There you have Mr. Webster’s liberal — the liberal of lore, the liberal of common understanding.

This liberal is a spacious and tolerant fellow. He is all right.

His liberalism is… if you will indulge me… the liberalism of this publication. We are with Jefferson:

“It does me no injury for my neighbor to say there are 20 gods, or no god. It neither picks my pocket nor breaks my leg.”

Nor does it pick my pocket — or break my leg — if a man lists politically to starboard or if he lists politically to port…

Or if he believes Donald John Trump is an angel of God or an angel of Satan.

It is all one to me.

The Transformation of Liberalism

Yet I fear today’s “liberalism” is not Webster’s liberalism. I fear pirates have hijacked her. And they steam under false colors.

In the identical spirit, Freedom Financial News contributor Jeffrey Tucker has authorized a fresh piece, “What It Means To Be A Former Liberal.”

Begins Mr. Tucker:

[Liberal] meant being for freedom generally and opposed to despotism and dictatorship by church or state.

Our Founding Fathers were considered liberals in a classical sense.

They wanted free speech, free elections, free enterprise, free formation of community, and so on, and wanted government restricted in its power.

That meaning of the word… lasted mostly until the Great War…

Matters got worse during the New Deal when even more “liberals” threw their weight behind industrial planning and corporatism.

Emerging out of World War II, there was nothing much remaining to the term. It had been completely co-opted by its enemies.

And after World War II?

SPONSORED: PARADIGM PRESS

FREE TICKER DROP!
(Watch to see Rare Pre-IPO Opportunity)

After years of research into Elon Musk’s critical technology projects, I have pinpointed an incredible opportunity off the back of his coming Starlink IPO…

An IPO set to break records as the biggest in history.

This opportunity is a single stock – revealed FREE – in this quick three-minute video.» Click Here for the Full Story «

The Long March Through the Institutions

As I wrote before:

In the 1960s “liberals” decried and denounced “the man” — the oppressive man. They sang their songs of freedom.

Yet they have since taken their long march through the institutions…and became the man they once despised…

Goose-stepping through the universities… through the government bureaucracy… through the newsrooms… through the production studios… through the human resources departments… through the philanthropic organizations.

Once safely ensconced therein, they raised the drawbridges and pulled up the ladders. The commanding heights were theirs.

Is it any wonder that trust in the Central Intelligence Agency and the Federal Bureau of Investigation is greatest among self-identified liberals in recent years?

Yet many liberals could not quite come into camp. They found themselves, in many respects, politically homeless.

‘That’s It, I Can’t Take It Anymore!’

Mr. Tucker:

I’m surrounded by people who call themselves “former liberals”…

They weren’t fans of the Cold War and really didn’t like the War on Terror.

They still champion civil liberties but gagged at woke ideology and especially the transgender agenda.

“Liberalism” became way too ill-liberal for them to stomach.

It was the COVID experience that really shattered them.

Once again, I am with Mr. Tucker. The excesses of the plague year horrified many “liberals.”

And so scales began falling from eyes:

All their friends in media, academia, and the corporate world went nuts. They were demanding that everyone lock themselves indoors, make the working class deliver food, cover the faces of children, close schools, censor speech, and then let medical workers inject the entire population with an untested substance of uncertain origin.

There was nothing liberal about any of that. So my liberal friends felt a great sense of alienation. It was not just that their communities abandoned their values. They began to wonder if their whole ideological outlook was wrong.

Maybe government won’t save us from corporatism after all. Maybe the media is not really a check on power… Maybe this has been going on for a long time and no one knew it.

And so?

Many Became “Red-Pilled”

As a result, many of these people feel homeless both intellectually and politically. They are warmer to Trump than they ever thought they would be but not uncritical. They still browse their old media venues with interest but often it turns to disgust…

They have become, in popular parlance, red-pilled…

I was speaking with a person the other day who referred to a friend of mine as having been red-pilled on some subject. It made me laugh because, so far as I know, the person in question pretty much held far-left views all his life… Today, he is hoping the Trump administration will save the nation from his former tribe.

My point is this. We live in very unusual times when the terms left and right have become enormously scrambled.

The Courage to Face Reality

What then is to be done? Do we require fresh terminology to transcend the left/right schism, Mr. Tucker?

Terms are always subject to mischaracterization and capture, as we see with the word liberal (and the word conservative actually).

What we need instead is open minds, the courage to look at facts and reality, and the willingness to say in public what we believe to be true. We can do all that without carrying the baggage of legacy ideologies.

In conclusion:

We know who the dissidents are from woke ideology, from Covidianism, from NPRism, from the matrix of mainstream media. Their legacy commitments are all over the map. We can encounter and learn from each other…

Still, my heart also breaks for those people who thought that they had found their tribe until it turned out that their tribe is dominated by crazy people. It’s a bit like losing a beloved pet or even a spouse. The comforts of familiarity have been taken away and we are left to fend for ourselves.

Now no thoughtful person is in a position to outsource his worldview to any leader or institution. Perhaps that is a good thing.

Why We Don’t Really Believe in Ourselves

Perhaps it is a good thing that no thoughtful person is in a position to outsource his worldview to any leader or institution, Mr. Tucker.

And this publication likes to think it holds out a beacon to such individuals.

We proudly accept outcasts and heretics from all existing orthodoxies.

Yet as Henry Louis Mencken styled it, we are entirely devoid of messianic passion. We hear no voice from the burning bush.

And we are better at raising questions than answering them. Most importantly perhaps, we refuse to take ourselves too seriously.

Thus we are with Chesterton:

“The men who really believe in themselves are all in lunatic asylums.”

Alas, the lunatic asylums are full.

Brian Maher

for Freedom Financial News

P.S. How Mitt Romney Turned $450K Into Up to $100 Million (Tax-Free)

It wasn’t stocks. It wasn’t real estate. It was a little-known investment vehicle that turned Mitt Romney’s $450,000 into as much as $100 million and Peter Thiel used to turn $2,000 into $5 billion within two decades. Now, thanks to a new executive order, regular Americans can access the same type of investment. (Ad)

Get more details here >>

Update your email preferences or unsubscribe here

435 Merchant Walk Square, Ste 300-64
Charlottesville, VA 22902, United States Terms of Service

RJ Hamster

StylesForLess

StylesForLess
— Read on stylesforless.com/

RJ Hamster

Shocking Footage From Houston Plant

Washington didn’t expect this footage to go public.

Inside Foxconn’s massive new facility in Houston, cameras captured NVIDIA’s CEO standing shoulder-to-shoulder with humanoid robots. Real machines — walking, turning, and working on the floor of what will become America’s first large-scale humanoid production line.

This isn’t decades away. Foxconn plans to begin production in 2026 — right here in the U.S. — rolling out two advanced models that could replace millions of workers.

Even President Trump, speaking at a recent rally, said: “We have to be very careful with where this is going.” But Washington is already betting big… and cutting contracts.

The real winners? Not the robot brands… but the 3 little-known companies supplying the hardware, chips, and systems for every AI humanoid built. These plays could move before the first Houston robots even ship.

If you wait for mainstream coverage, you’ll be too late.See Which 3 Stocks Power America’s AI Factory A special message from the Editor of Smart Future Revenue: We are often approached by other businesses with special offers for our readers. While many don’t make the cut, the message above is one we believe deserves your consideration.

Thinking about unsubscribing? Just tap the link.

SmartFutureRevenue.com is provided under the management of Sparks Affiliates, LLC.
Have questions? Contact us at support@smartfuturerevenue.com.

Stop receiving our marketing communications by unsubscribing here.

848 Main St Ste 10, Billings, MT 59105.

RJ Hamster

Early Coverage: See Why (MTVA) Just Jumped On to…

Any content you receive is for information purposes only. Always conduct your own research.

*Sponsored

New on Our Radar: Market Crux Just Put (MTVA) This Morning’s Watchlist

See Why We Have All Eyes On (MTVA) Heading Into

Friday’s Session—February 13, 2026

Don’t Miss The Next Breakout—Get Real-Time Alerts Sent Directly

To Your Phone. Up To 10X Faster Than Email.

Pull Up (MTVA) While It’s Still Early…

February 13, 2026

Early Coverage | See Why (MTVA) Just Jumped On to Our Morning Watchlist

Dear Reader,

Healthcare is entering a period where metabolic dysfunction—and the downstream conditions it drives—has moved to the center of chronic disease strategy.

That shift is showing up not just in clinical priorities, but in the size and momentum of multiple therapeutic categories tied to weight, glucose regulation, and liver health.

Start with obesity: the anti-obesity therapeutics market is projected to expand at a 29.2% CAGR, reaching $67.16B by 2034. The broader cardiometabolic landscape is also moving higher, with the global cardiometabolic therapeutics market expected to grow from $68.4B in 2026 to over $111B by 2035.

Diabetes remains a major pillar within that ecosystem. The global T2D therapeutics market is forecast to reach $76.39B by 2034, while the broader diabetes therapeutics category is projected as high as $283.36B over the same timeframe.

Liver disease adds another fast-growing layer. The MASH (Metabolic Dysfunction-Associated Steatohepatitis) therapeutics market—often described as a condition that can progress quietly for years—is projected to rise from $12.7B in 2026 to $92.5B by 2034.

Similar categories, including broader liver disease therapeutics (projected $50.4B by 2034) and inflammatory disease therapeutics (projected $293.4B by 2035), reinforce how interconnected these pathways have become.

And increasingly, that interconnected biology is being mapped with computational tools. AI-modeling collaborations are now being used to identify and validate disease targets across inflammation and cardiometabolic pathways—sometimes surfacing signals that overlap with fields like oncology, a market projected at $667.28B.

Against this backdrop, MetaVia Inc. (Nasdaq: MTVA) is advancing clinical-stage programs aimed at obesity and liver disease, and has reported results from an AI-modeling collaboration that aligns its work with key inflammatory and cardiometabolic targets.

That’s part of why (MTVA) is topping our watchlist this morning—Friday, February 13, 2026.

But keep in mind, (MTVA) has less than 985K shares listed as available to the public. When companies have a razor-thin float like this, the potential exists for sharp moves if demand begins to shift.

Right now, (MTVA) is sitting below $2and appears to be flying under the radar of many screens.

That’s where it can help to look at what the chart is signaling in the near term—especially when sentiment has cooled.

Technical readings show the RSI levels for (MTVA) have drifted below 30 for its 9-day, 14-day, and 20-day time-frames—levels that some would describe as near “oversold territory”, which could indicate a potential trend reversal is in the works.

And when a company posts attention-grabbing clinical news in massive therapeutic categories, it’s not unusual for analyst commentary to turn sharply more ambitious—sometimes very quickly.

Recent Analyst Targets Suggest 3,000% to 3,400% Upside Potential

Several biotechnology analysts have begun to set targets that suggest (MTVA) is significantly overlooked relative to its recent clinical success:

Maxim Group: Analyst Jason McCarthy, Ph.D., has set a $55 target on MTVA, suggesting over 3,000% upside potential from its recent range.
Zacks SCR: Analyst David Bautz, Ph.D., has set a $60 target on MTVA, suggesting over 3,400% upside potential.

Taken together—large, fast-expanding therapeutic categories, recent clinical updates, and AI-enabled validation—(MTVA) is starting to look like one of those under-followed stories that can change quickly once more people connect the dots.

Before we go any further, it helps to understand exactly what (MTVA) is building and why its approach is different.

Company Overview: Engineering the Future of Metabolic Health

MetaVia Inc. (Nasdaq: MTVA) is a clinical-stage biotechnology companydedicated to transforming the treatment of cardiometabolic diseases. Formerly known as NeuroBo Pharmaceuticals, the company underwent a strategic rebranding to MetaVia to better align with its focus on the “Metabolic-Vascular” axis.

Headquartered in Cambridge, MA, the company operates with a high-efficiency team and deep strategic ties to South Korean pharmaceutical giant Dong-A ST.

What makes (MTVA) distinctive is its reliance on “dual-agonist” and “gut-pep-tide” engineering. Its lead candidate, DA-1726, is a novel oxyntomodulin (OXM) analogue that simultaneously activates the glucagon-like pep-tide-1 receptor (GLP1R) and the glucagon receptor (GCGR).

While first-generation treatments often prioritize appetite suppression alone, DA-1726 aims to decrease food intake while increasing energy expenditure. This dual action mimics the body’s natural gut hormones to potentially produce superior weight loss and metabolic improvement compared to selective GLP1R agonists.

Simultaneously, the company is advancing vanoglipel (DA-1241), a novel G-protein-coupled receptor 119 (GPR119) agonist. This oral therapy promotes the release of endogenous GLP-1, GIP, and PYY. In clinical studies, vanoglipel has demonstrated the ability to reduce liver inflammation and fibrosis, providing a powerful one-two punch against MASH and Type 2 diabetes.

Best-in-Class Potential: The DA-1726 Breakthrough

In January 2026, (MTVA) released statistically significant results from its Phase 1b trial of DA-1726. The data from an 8-week cohort was nothing short of remarkable: patients achieved a 9.1%reduction in body weight (averaging 21.2 lbs) and a nearly 10 cm (3.8 inch) reduction in waist circumference.

Furthermore, the trial showed a 23.7%reduction in liver stiffness (VCTE) in just 54 days. These results highlight the “glucagon effect”—where increasing energy expenditure targets visceral fatand liver health more aggressively than standard therapies.

With no treatment-related discontinuations and a favorable safety profile, MTVA is setting a high bar for the next generation of weight-loss solutions.

AI-Driven Precision: The Syntekabio Collaboration

The company’s recent February 4, 2026 announcement confirmed that its collaboration with Syntekabio is yielding high-value insights. Using the DeepMatcher® AI platform, (MTVA)confirmed that vanoglipel strongly engages inflammatory and cardiometabolic target pathways.

This validation is critical for the upcoming Phase 2b studies and potentially opens the door to oncology applications, as the AI identified strong anti-inflammatory signatures that could address cancer-related pathways.

Financial Strength and Execution Runway

(MTVA) began 2026 by completing a $9.3M underwritten public offering, including the full exercise of the over-allotment option, adding capital intended for working capital and the continued clinical development of DA-1726.

Readers who want the full structure and terms can review the company’s announcement here.

The management team, led by CEO Hyung Heon Kim and Chairman Andrew Koven—a former executive at Warner-Lambert and Merck—possesses the clinical and operational depth required to transition from a mid-stage biotech to a commercial-stage contender.

7 Reasons Why (MTVA) is Topping Our Watchlist This Morning

—Friday, February 13, 2026.

1. Analyst Attention: Following recent clinical updates, (MTVA) has drawn published targets from multiple biotechnology analysts that imply roughly 3,000% to 3,400% upside potential versus the range referenced in your text.

2. Limited Float: (MTVA) has fewer than 985K shares listed as available to the public, a structure that can heighten sensitivity to changing attention.

3. Technical Setup: (MTVA) recently showed RSI readings below 30 across multiple timeframes, levels some associate with “oversold territory” and a setup for a potential trend reversal.

4. Massive End-Markets: Across obesity ($67.16B by 2034), cardiometabolic therapeutics (over $111B by 2035), T2D therapeutics ($76.39B by 2034), and MASH therapeutics ($92.5B by 2034), (MTVA) is positioning itself within multiple large categories projected to expand over the next decade.

5. Clinical Momentum: (MTVA)reported statistically significant Phase 1b results showing measurable reductions in body weight, waist circumference, and liver stiffness within 8 weeks.

6. Dual Programs: (MTVA) is advancing two distinct clinical-stage candidates—DA-1726 and vanoglipel—addressing both metabolic and liver-related conditions.

7. AI Validation: (MTVA) has confirmed through an AI-modeling collaboration that its biology aligns with key inflammatory and cardiometabolic targets.

Pull Up (MTVA) While It’s Still Early…

In the world of high-stakes biotechnology, data is the only currency that matters. MetaVia Inc. (Nasdaq: MTVA) has consistently delivered clinical results that not only meet but often exceed expectations for mid-stage candidates.

The company’s ability to target the most lucrative sectors in healthcare—obesity and liver disease—while leveraging AI-driven precision sets it apart from a sea of competitors.

As MTVA advances toward its titration studies in late 2026 and further Phase 2b MASH milestones, the narrative of a transformation in cardiometabolic health is becoming impossible to ignore.

For anyone closely monitoring the future of weight loss and metabolic restoration, (MTVA) is a symbol that could demand immediate attention as its clinical story continues to unfold.

We have all eyes on (MTVA) this morning—Friday, February 13, 2026.

Consider starting your own research on (MTVA) while it’s still early.

Also, keep a lookout for my next update, it could be coming very shortly.

Sincerely,

Gary Silver

Managing Editor,

Market Crux

MarketCrux.com (“MarketCrux” or “MC” ) is owned by Headline Media LLC, MC is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MC brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.

Pursuant to an agreement between Headline Media LLC and TD Media LLC, Headline Media LLC has been hired for a period beginning on 02/13/2026 and ending on 02/13/2026 to publicly disseminate information about (MTVA:US) via digital communications. Under this agreement, TD Media LLC has paid Headline Media LLC seven thousand five hundred USD (“Funds”). These Funds were part of the thirty five thousand USD funds that TD Media LLC received from a third party named JRZ Capital LLC who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.

Neither Headline Media LLC, TD Media LLC and their member own shares of (MTVA:US).

Please see important disclosure information here: https://marketcrux.com/disclosure/mtva-DEPiO/#detailsHeadline Media7901 4th Street NSuite 300St. Petersburg, FL 33702Unsubscribe Update Profile | Constant Contact Data NoticeSent by gary@marketcrux.net